Amerithroid Tablet
Product Images NDC 82685-342

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Amerithroid (NDC 82685-342). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oliva Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (15 mg Tablet Bottle Label)

FDA Label Image

Principal Display Panel (30 mg Tablet Bottle Label)

FDA Label Image

Principal Display Panel (60 mg Tablet Bottle Label)

FDA Label Image

Principal Display Panel (90 mg Tablet Bottle Label)

This is a prescription label for a medication containing levothyroxine and liothyronine tablets. The storage instructions indicate that the tablets should be stored in a tightly closed container protected from light and moisture at temperatures between 15°C-30°C (59°F-86°F). The information is subject to revision by January 2025.*

FDA Label Image

Principal Display Panel (120 mg Tablet Bottle Label)

FDA Label Image

Principal Display Panel (180 mg Tablet Bottle Label)

FDA Label Image

Principal Display Panel (240 mg Tablet Bottle Label)

FDA Label Image

Principal Display Panel (300 mg Tablet Bottle Label)

The text describes a medication container for levothyroxine tablets, each containing 190 mcg of the active ingredient. It provides storage instructions to keep the tablets in a tightly closed container, protected from light and moisture, stored between 15° - 30°C (59° - 86°F). The revision date is 01/2025.*

FDA Label Image

Levo-chemical-structure (Levo Structure)

FDA Label Image

Lio-chemical-structure (Lio Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.